Sign up to save your podcasts
Or
Share 179 - Could Severe Tinnitus be Treated with a Brain Implant? New Technology Under Development Holds Promise
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
179 - Could Severe Tinnitus be Treated with a Brain Implant? New Technology Under Development Holds Promise
Neurosoft Bioelectronics is leading the way in the development of sophisticated soft implantable electrodes designed to interact with the brain and address severe neurological disorders. In this week's discussion, host Bob Traynor engages in a conversation with CEO Nicolas Vachicouras, delving into the company's pioneering initiatives to create an implantable brain interface device aimed at treating severe tinnitus.
The technology employs ultra-thin, flexible electrodes capable of both recording brain activity and delivering personalized electrical stimulation patterns, guided by AI algorithms. The overarching objective is to regulate hyperactive networks associated with conditions such as tinnitus through a closed-loop system. Human trials have substantiated the safety and effectiveness of these electrodes in recording brain activity. Neurosoft's strategic roadmap includes the launch of a product for epilepsy and the initiation of a specialized feasibility study for treating severe tinnitus.
With a minimally invasive implantation procedure, this technology holds the potential to offer long-term relief for individuals grappling with chronic tinnitus. Neurosoft envisions introducing new treatment options within 4-5 years, pending further development and regulatory approval.
More information on the technology can be found on the company's website: https://neurosoft-bio.com/index
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
View all episodes
By This Week in Hearing
5
11 ratings
Neurosoft Bioelectronics is leading the way in the development of sophisticated soft implantable electrodes designed to interact with the brain and address severe neurological disorders. In this week's discussion, host Bob Traynor engages in a conversation with CEO Nicolas Vachicouras, delving into the company's pioneering initiatives to create an implantable brain interface device aimed at treating severe tinnitus.
The technology employs ultra-thin, flexible electrodes capable of both recording brain activity and delivering personalized electrical stimulation patterns, guided by AI algorithms. The overarching objective is to regulate hyperactive networks associated with conditions such as tinnitus through a closed-loop system. Human trials have substantiated the safety and effectiveness of these electrodes in recording brain activity. Neurosoft's strategic roadmap includes the launch of a product for epilepsy and the initiation of a specialized feasibility study for treating severe tinnitus.
With a minimally invasive implantation procedure, this technology holds the potential to offer long-term relief for individuals grappling with chronic tinnitus. Neurosoft envisions introducing new treatment options within 4-5 years, pending further development and regulatory approval.
More information on the technology can be found on the company's website: https://neurosoft-bio.com/index
Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
More shows like This Week in Hearing
View all
Pivot
9,140 Listeners
The Daily
111,746 Listeners
The Indicator from Planet Money
9,555 Listeners
Interesting Times with Ross Douthat
6,751 Listeners
The Audiologist
2 Listeners
Hearing Matters Podcast
16 Listeners
The Ezra Klein Show
15,220 Listeners
The Weekly Show with Jon Stewart
10,508 Listeners